Antimicrobial photodynamic therapy using chlorin e6 with halogen light for acne bacteria-induced inflammation. 2015

Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
Department of Medical Science, Soonchunhyang University, Asan, Chungnam 336-600, Republic of Korea.

OBJECTIVE The present study was designed to evaluate the therapeutic potential of antimicrobial photodynamic therapy (PDT) using chlorin e6 with halogen light against acne bacteria-induced inflammation. METHODS Highly purified chlorin e6 (Ce6), as a second generation photosensitizer, was synthesized from Spirulina chlorophyll. To evaluate the antimicrobial property of Ce6-mediated PDT with halogen light, the broth microdilution method and two-color fluorescence assay were used. The free radicals generated upon irradiating Ce6 with halogen light were measured using 2,7-dichlorofluorescin diacetate. Propionibacterium acnes was intradermally injected into the left ear of the ICR mice, and the anti-inflammatory effect of Ce6-mediated PDT with halogen light was measured by the histological examination. The expressions of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) as well as pro-inflammatory cytokines were also measured by Western blotting. RESULTS Chlorin e6-mediated PDT with halogen light (30,000 lx) inactivated various skin bacteria, including P. acnes in a dose-dependent manner. The MIC99 value against P. acnes (KCTC3314) of Ce6 with light was >0.49 μg/ml, whereas the MIC99 for Ce6 alone was >31.25 μg/ml. Ce6-mediated PDT suppressed the expression of P. acnes-induced pro-inflammatory cytokines and iNOS, but not COX-2 in a mouse model. CONCLUSIONS This study showed a remarkable therapeutic effect of chlorin e6-mediated PDT with halogen light against P. acnes-induced inflammation. Our results suggest for the first time the potential of Ce6-mediated PDT with halogen light as a more effective and safer alternative treatment to antibiotic therapy against pathogenic infections of the skin.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D011425 Propionibacterium acnes A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants. Corynebacterium acnes,Corynebacterium parvum
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D002735 Chlorophyllides Products of the hydrolysis of chlorophylls in which the phytic acid side chain has been removed and the carboxylic acids saponified. Chlorophyllide
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
September 2010, Lasers in medical science,
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
September 2016, Photodiagnosis and photodynamic therapy,
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
December 2013, Biomaterials,
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
May 1988, Journal of the National Cancer Institute,
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
October 2016, ACS applied materials & interfaces,
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
January 1999, Journal of hepato-biliary-pancreatic surgery,
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
December 2021, Molecules (Basel, Switzerland),
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
December 2017, Journal of materials chemistry. B,
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
April 2019, Journal of nanobiotechnology,
Yu-Mi Jeon, and Hwan-Suk Lee, and Dongjun Jeong, and Hae-Keun Oh, and Kyu-Hwan Ra, and Mi-Young Lee
June 2009, Photodiagnosis and photodynamic therapy,
Copied contents to your clipboard!